[PLX] YoY Quarter Result on 31-Mar-2024 [#Q1]

Stock
[PLX] Protalix BioTherapeutics, Inc.
Announcement Date
10-May-2024
Financial Year
2024
Quarter
31-Mar-2024 [#Q1]
Profit Trend
QoQ- 23.97%
YoY- -46.76%
Quarter Report
PLX's Result
PLX's Financial Summary
View:
Show?
Quarter Result
31/03/24 31/03/23 31/03/22 31/03/21 31/03/20 31/03/19 31/03/18 CAGR
Revenue 3,748 9,588 16,085 11,320 21,646 10,439 4,553 -3.18%
PBT -4,733 -2,936 -2,286 -5,475 1,667 -7,264 -9,400 -10.79%
Tax -138 195 416 2,207 203 190 132 -
NP -4,595 -3,131 -2,702 -5,475 1,667 -7,264 -9,400 -11.23%
Tax Rate - - - - -12.18% - - -
Total Cost 8,343 12,719 18,787 16,795 19,979 17,703 13,953 -8.20%
Ratio Analysis
31/03/24 31/03/23 31/03/22 31/03/21 31/03/20 31/03/19 31/03/18 CAGR
NP Margin -122.60 -32.66 -16.80 -48.37 7.70 -69.59 -206.46 -8.31%
Per Share
31/03/24 31/03/23 31/03/22 31/03/21 31/03/20 31/03/19 31/03/18 CAGR
EPS -0.06 -0.05 -0.06 -0.14 0.10 -0.49 -0.65 -32.74%
EPS Diluted -0.06 -0.05 -0.06 -0.14 0.10 -0.49 -0.65 -32.74%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.